Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 5915 | 430 | 0.2777 | 0.2714 | 0.0727 | 0.0654 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 9020 | 322 | 0.4553 | 0.4801 | 0.0357 | 0.0412 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 9132 | 411 | 0.4565 | 0.3648 | 0.0450 | 0.0413 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 6541 | 255 | 0.3291 | 0.3648 | 0.0390 | 0.0413 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 3016 | 167 | 0.1443 | 0.1539 | 0.0554 | 0.0544 |
COLO 858 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 7914 | 1171 | 0.9632 | 1.0000 | 0.1480 | 0.1514 |
COLO 858 | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 2337 | 557 | 0.2543 | 0.2671 | 0.2383 | 0.2394 |
COLO 858 | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 2951 | 631 | 0.3314 | 0.2671 | 0.2138 | 0.2394 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 19971 | 929 | 0.9642 | 1.0000 | 0.0465 | 0.0504 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 22233 | 990 | 1.0180 | 1.0000 | 0.0445 | 0.0468 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 21096 | 999 | 0.9631 | 1.0000 | 0.0474 | 0.0468 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 22342 | 1082 | 1.0188 | 1.0000 | 0.0484 | 0.0468 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 16963 | 834 | 0.7730 | 0.8197 | 0.0492 | 0.0506 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 18341 | 936 | 0.8341 | 0.8197 | 0.0510 | 0.0506 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 18747 | 969 | 0.8520 | 0.8197 | 0.0517 | 0.0506 |
A-375 | Vemurafenib | Defactinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 9567 | 390 | 0.4398 | 0.4342 | 0.0408 | 0.0408 |
A-375 | Vemurafenib | Defactinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 10229 | 430 | 0.4696 | 0.4342 | 0.0420 | 0.0408 |
A-375 | Vemurafenib | Defactinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 8546 | 338 | 0.3934 | 0.4342 | 0.0396 | 0.0408 |
A-375 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 2168 | 298 | 0.0896 | 0.0889 | 0.1375 | 0.1262 |
A-375 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 2198 | 268 | 0.0925 | 0.0889 | 0.1219 | 0.1262 |
A-375 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 2006 | 239 | 0.0847 | 0.0889 | 0.1191 | 0.1262 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 3339 | 171 | 0.1604 | 0.1539 | 0.0512 | 0.0544 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 3 | 11246 | 370 | 0.6841 | 0.6866 | 0.0329 | 0.0312 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 9513 | 1495 | 0.9520 | 1.0000 | 0.1572 | 0.1501 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 10083 | 1500 | 1.0190 | 1.0000 | 0.1488 | 0.1501 |